Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1997;75(4):606-7.
doi: 10.1038/bjc.1997.106.

Phase II study of paclitaxel in pretreated patients with locally advanced/metastatic cancer of the bladder and ureter

D Papamichael  1 , C J Gallagher, R T Oliver, P W Johnson, J Waxman
Affiliations
Free PMC article
Clinical Trial

Phase II study of paclitaxel in pretreated patients with locally advanced/metastatic cancer of the bladder and ureter

D Papamichael et al. Br J Cancer. 1997.
Free PMC article

Abstract

Fourteen patients with previously treated, locally advanced/metastatic transitional cell carcinoma (TCC) of the bladder or ureter received paclitaxel at a dose of 200 mg m-2 administered as a 3-h infusion every 21 days. The activity of paclitaxel in this group of patients was modest. The response rates were one partial response (PR) (7%) and three stable disease (SD). There were two early deaths.

PubMed Disclaimer

References

    1. Ann Intern Med. 1989 Aug 15;111(4):273-9 - PubMed
    1. Semin Surg Oncol. 1992 Sep-Oct;8(5):316-41 - PubMed
    1. J Natl Cancer Inst. 1993 Mar 3;85(5):384-8 - PubMed
    1. Clin Cancer Res. 1995 Mar;1(3):247-56 - PubMed
    1. J Clin Oncol. 1994 Nov;12(11):2264-70 - PubMed

Substances